NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email As a new CEO takes the Disney reins, TV chief Dana Walden will add oversight of Disney’s film studio operations to her purview, but not ESPN.Read More